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ABSTRACT
Accurately established reference intervals are essential to interpret laboratory test results and assess 
patient health. Poorly established reference intervals can lead to misdiagnosis, subjecting patients to 
anxiety, unnecessary testing, and/or infection risk. The clinical importance of reference intervals is well 
recognised. However, establishing robust reference intervals is a complex process, especially for the 
paediatric population. Therefore, available reference intervals are often incomplete, cover a limited pae-
diatric age interval, and/or do not consider gender differences. CALIPER, a collaborative study among 
Canadian paediatric centres, is addressing these critical gaps by determining age- and sex-specific 
paediatric reference intervals for over 80 biomarkers using samples collected from over 8,500 children 
and adolescents. These reference intervals established on the Abbott ARCHITECT have been transferred 
to other major analytical platforms, broadening the utility of the CALIPER database. The effect of diurnal 
variation, post-prandial effects, biological variation, and storage temperature on analyte concentration has 
also been assessed. Knowledge translation initiatives, including peer-reviewed publications, an online 
database, and a smartphone application, allow physicians and laboratory technicians worldwide to easily 
access the CALIPER database. This project has made great progress in addressing critical knowledge gaps 
in paediatric reference intervals, ultimately benefiting paediatric healthcare across Canada and globally.
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Introduction
Reference intervals established from a healthy 
population are critical to accurately interpret laborato­
ry tests. Reference intervals or ‘normative values’ are 
defined as the central 95% of values from a healthy 
reference population. Test results that lie outside this 
range are considered abnormal, and often indicate that 
the patient requires additional testing and/or medical 
treatment. Therefore, poorly established or inappropri­
ate reference intervals can lead to misdiagnosis and 
can subject patients to further anxiety, unnecessary 
testing, and/or infection risk. Although the importance 
of reference intervals in the clinical setting is well rec­
ognised, the process of establishing reliable reference 
intervals is quite complex. In addition, with the signi­
ficant advances in technology and increases in newly 
identified biomarkers for disease, published reference 
intervals quickly become out­of­date. Therefore, there 
is an urgent need to update existing reference inter­
vals, and also to establish robust reference intervals 
for newer tests. 
In order to be accurate, reference intervals must 
be established from a large, healthy population. Addi­
tionally, appropriate inclusion/exclusion criteria must 
be applied to ensure that only healthy individuals are 
included. The normal levels of many biomarkers can 
also be influenced by physical size, organ maturity, 
rates of growth and development, immune and hor­
mone responsiveness, nutrition, and metabolism [1, 2]. 
Therefore, these factors must be considered when es­
tablishing reference values, and adult reference intervals 
are not applicable in the paediatric setting. Specifically, 
the paediatric population poses additional challenges 
when establishing reference intervals. Children respond 
differently to infections compared to adults, and are also 
8folia Medica copernicana 2015, vol. 3, no. 1
www.fmc.viamedica.pl
exposed to unique infections as a result of their ‘immuno­
logically naïve’ state [3]. In addition, obtaining parental 
consent is necessary when recruiting children and ado­
lescents, and attaining sufficient sample volume can be 
difficult, especially from neonates. In some cases, parti­
tioning of the reference population may also be required 
when there are significant differences between subgroups 
of different ages, genders, or ethnicities. According to 
the Clinical Laboratory Standards Institute (CLSI) guide­
line C28­A3, 120 samples per partition are necessary 
to generate significantly robust reference intervals [4], 
and depending on the number of partitions needed, the 
resulting sample size required can be very large.
Based on current literature, the vast majority of pre­
viously established paediatric reference intervals have 
been incomplete, covered a limited paediatric age inter­
val, and/or have not always considered both genders. 
Our group has reviewed the literature and identified 
critical gaps in reference intervals for four paediatric 
sub­specialties, including bone markers [5], risk 
markers for cardiovascular disease and metabolic 
syndrome [6, 7], hormones of the thyroid and growth 
hormone axes [8], and markers of inborn errors in 
metabolism [9]. In summary, this research found that 
existing reference intervals have been established 
using outdated instruments and methodologies, 
and/or protocols that were not in accordance with 
currently recommended guidelines; thus, previously 
established paediatric reference intervals are generally 
inappropriate. Increased awareness that the use of 
unsuitable reference values can pose potential patient 
safety risks by subjecting children to unnecessary 
further blood collection, infection risk, and lengthier 
hospital stays, has led to the development of global 
initiatives to address the critical gaps in paediatric 
reference intervals. These initiatives include the 
Children’s Health Improvement through Laboratory 
Diagnostics (CHILDx) programme in the United States 
(www.childx.org), the German Health Interview and 
Examination Survey for Children and Adolescents (Ki­
GGS) in Germany [10], and the Canadian Laboratory 
Initiative on Paediatric Reference Intervals (CALIPER) 
in Canada [1, 2, 11]. The CALIPER project was initiated 
by The Paediatric Focus Group of the Canadian So­
ciety of Clinical Chemists to address the critical gaps 
in paediatric reference intervals. This collaborative 
project between seven paediatric hospitals across 
Canada (in St. John’s, Montreal, Toronto, Ottawa, 
Hamilton, Saskatoon, and Vancouver) has made 
significant strides towards improving healthcare for 
the paediatric population in Canada, and globally. 
The significant progress that CALIPER has achieved 
through initial pilot studies, large­scale reference in­
terval studies for over 80 paediatric biomarkers, and 
various sub­studies will be reviewed here.
Pilot studies
In the initial pilot phases of the CALIPER project, stud­
ies were performed to analyze levels of 14 chemistries 
and immunoassays [12], and later, an additional 15 im­
munoassays and 24 chemistries [13], all using the Abbott 
ARCHITECT ci8200 analyser. Across these two studies, 
a total of 2,809 serum and plasma specimens were col­
lected from apparently healthy and metabolically stable 
paediatric subjects attending outpatient clinics [13]. 
Age­ and gender­specific reference intervals were es­
tablished according to CLSI/IFCC C28­P3 guidelines, 
with the upper and lower limits defined as the 2.5th 
and 97.5th percentiles, and corresponding 95% confi­
dence intervals were determined for each limit [4, 13]. 
Reference intervals were established for five age 
groups, chosen somewhat arbitrarily: birth–12 months, 
1–5 years, 6–10 years, 11–14 years, and 15–18 years [13]. 
These studies were an important initial step for this 
project, but limitations were still apparent. Namely, 
samples were collected from outpatients rather than 
healthy community children, and the recommended 
number of 120 specimens for each subgroup was not 
always collected, especially in the birth–12 months age 
group [12, 13].
In 2010, 25 common analytes were studied in an­
other pilot study using the OrthoVitros 5600 Integrated 
System. The results were partitioned based on sex and 
age, according to five arbitrarily chosen age groups, 
which were merged if deemed appropriate [14]. In this 
study, the Robust method of Horn and Pesce (Horn 
2005) was used to calculate reference intervals, as 
the requirement to obtain a minimum sample size of 
120 or greater per partition could not be met [14]. 
In the same year, another pilot study was performed for 
11 chemistries and 17 immunoassays on the Roche Co­
bas 6000 analyzer, using 600 outpatient samples [15]. 
Data was stratified by gender and five arbitrarily chosen 
age groups, but due to the limited number of collected 
specimens it was necessary to combine some age 
partitions [15]. 
In 2011, the Roche Modular Analytics E 170 sys­
tem was used to determine reference intervals for 
free thyroxine (fT4) and thyroid stimulating hormone 
(TSH), for two predetermined age groups: 1–6 and 
7–17 years, but reference intervals were not stratified 
by gender (Henderson 2011). That same year, age­ and 
gender­specific reference intervals were determined 
for five bone markers, and the effects of BMI­z score, 
Vitamin D3, and parathyroid hormone (PTH) on the le­
vels of these analytes were investigated (Huang 2011). 
Although these pilot studies were important in assessing 
the feasibility of, and establishing a foundation for, the 
CALIPER project, many limitations still needed to be 
addressed in order to generate robust and accurate 
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reference intervals that could be used to improve 
paediatric healthcare across Canada, and worldwide. 
At this stage, the aims for CALIPER were to obtain an 
extensive number of blood samples from a cohort of 
healthy community children and adolescents and to 
establish appropriately partitioned age and gender­spe­
cific paediatric reference intervals from the neonatal age 
to the end of adolescence.
A priori reference interval studies in 
healthy community children
Since 2009, CALIPER began its a priori studies, 
where healthy community children and adolescents 
have been recruited to establish a biobank of serum 
samples that can be used to establish representative 
reference intervals for a large number of clinically rel­
evant paediatric tests. More than 8,500 children and 
adolescents have been recruited as a result of the 
CALIPER promotional campaign. Since 2012, CALIPER 
has established paediatric reference intervals for over 
80 biochemical analytes, including 40 biomarkers as­
sessed on the Abbott ARCHITECT C8000 system [16], 
21 on the Abbott ARCHITECT i2000SR [17, 18], 11 us­
ing the Abbott ARCHITECT ci4100 [19], eight using 
the Sciex 4000 QTRAP mass spectrometer [20], and 
two using High Performance Liquid Chromatography 
(HPLC) [21]. All paediatric reference intervals have 
been published in high­impact scientific journals and 
are easily accessible through the CALIPER website 
(www.caliperdatabase.com), as well as the recently 
developed smartphone application.
In a study published in 2012, samples from 2,188 he ­ 
althy children and adolescents (1–18 years) from the 
greater Toronto area were used to establish refer­
ence intervals for 40 biochemical markers using the 
Abbott ARCHTIECT c8000 system [16]. However, 
for participants < 1 year of age, samples from selected 
outpatient clinics were used. The ethnic composition of 
participants was based on the 2006 Canadian census 
data for the province of Ontario, with the major ethnic 
groups appropriately represented, including Cauca­
sians, East Asians, and South Asians [16]. Statistically 
significant differences were observed among the three 
major ethnic groups for seven of the 40 analytes, but 
the sample sizes for ethnicities other than Caucasian 
were too small to determine reliable reference intervals 
by ethnicity [16]. Results showed that child growth and 
development greatly affected normal analyte levels in 
the healthy paediatric population (especially during the 
first 14 days after birth), and further partitioning by gen­
der was also necessary for a number of biomarkers. This 
was the first study to establish reference intervals based 
on a large number of samples collected from healthy 
community children of various ethnic backgrounds. 
In contrast, previous studies used samples from hospi­
talized patients [22], or determined reference intervals 
from small sample sizes [20, 23] or homogenous 
populations [24].
In 2013, CALIPER analyzed seven fertility hormones 
and eight steroid hormones using the Abbott ARCHI­
TECT i2000SR system and the Sciex 4000 QTRAP mass 
spectrometer, respectively [18, 20]. Reference intervals 
for seven fertility hormones were stratified by age, sex, 
and Tanner stage, to further explore the effect of sexual 
development on endocrine marker concentrations [18]. 
Samples from 1,234 community children and adoles­
cents (aged 0–18) were used, with the exception of 
children < 1 year of age, where again samples were 
collected from apparently healthy neonates and children 
in hospital maternity wards and selected outpatient 
clinics [18]. Similarly to the previous study, differences 
in analyte concentrations between ethnic groups were 
observed for some analytes; however, the small sample 
size for some ethnic groups prohibited calculation of 
ethnicity­specific reference intervals [18]. Many age 
partitions were required for all fertility hormones, with 
additional gender partitioning for a number of markers, 
further illustrating the importance of considering the 
effects of developmental changes when establishing 
paediatric reference intervals [18]. Age­ and sex­spe­
cific reference intervals were also determined for 
eight steroid hormones using samples obtained from 
337 healthy participants [20]. Age partitioning was 
needed, especially within the first 14 days, which was 
in agreement with previous CALIPER studies [16, 18]. 
In 2013, another 1,482 samples from the CALIPER 
biobank were analyzed on the Abbott ARCHITECT 
i2000SR to calculate age­ and sex­specific reference 
intervals for an additional 14 endocrine and specialty 
biochemical markers [17].
Most recently, in 2014, additional studies deter­
mined age­ and sex­specific reference intervals for 
Vitamins A and E using 342 blood samples [21], and for 
11 cancer biomarkers using between 400 and 700 sam­
ples, depending on the analyte [25]. Vitamins A and E 
were analyzed using High Performance Liquid Chro­
matography (HPLC) [21] and cancer biomarkers were 
measured using the Abbott ARCHITECT ci4100 [19]. 
In these more recent studies, CALIPER expanded its 
collection sites to the Hamilton region as well as the 
greater Toronto area. 
Transference studies
Most CALIPER reference intervals have been 
established using Abbott ARCHITECT assays, mean­
ing that the database was initially only applicable to 
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laboratories using the Abbott ARCHITECT platform, 
thereby limiting the information to only a subset of 
paediatric centres. Establishing de novo reference 
intervals for every common analytical platform can 
be very complex, challenging, and costly; therefore, 
CALIPER has used a method for transferring the 
reference intervals established in one laboratory (do­
nor) to other (receiving) laboratories, based on the 
CLSI guidelines [4]. The first step in this process is to 
assess the degree of similarity between methods by 
running patient samples on both systems, in order to 
establish the comparability of the two analytical sys­
tems under study [4]. If there is sufficient correlation 
between assay results on the two systems, and bias 
compared to the old system is negligible, a mathemat­
ical relationship between the two analytical systems 
can be determined and used to calculate new refer­
ence intervals for the receiving laboratory [4]. Next, 
the receiving laboratory must validate the transferred 
reference intervals using a relatively small number 
of samples obtained from healthy individuals [4]. 
In 2013, CALIPER performed a series of studies to 
transfer and validate the reference intervals established 
for the Abbott ARCHITECT to assays performed on four 
other commonly used clinical chemistry analyzers [26]. 
Specifically, 28 basic chemistry assays were trans­
ferred to the Siemens Vista 1500 platform, 16 to the 
Beckman Coulter DxC800, 21 to Ortho Vitros 5600, 
and 19 to Roche Cobas 6000 [26]. The assay­specific, 
age­ and sex­stratified paediatric reference intervals 
presented in this study greatly expanded the utility of 
the CALIPER reference interval database, and have 
increased the applicability of CALIPER reference 
intervals to paediatric centres across Canada, and 
worldwide [26]. 
CALIPER substudies
Additional CALIPER studies have focused on the 
examination of other factors that can alter analyte 
concentrations in the healthy population. These in­
clude diurnal variation [27], post­prandial effects [27], 
biological variation [28], and storage temperature [29]. 
Additionally, CALIPER has assessed the validity of es­
tablishing paediatric reference intervals based on data 
obtained from hospitalized patients, in contrast to our 
own database established from samples obtained from 
healthy children [30]. 
In 2012, CALIPER determined the stability of chem­
istry, protein, and hormone analytes stored at –80°C on 
three analytical instruments (i.e. Ortho Vitros Chemistry 
System, Roche Cobas Integra 400 Plus, and Siemens 
Immulite 2500) [29]. Samples from children (aged 0–18) 
were analyzed for 57 biochemical markers at monthly in­
tervals over a 10–13 month period and each aliquot was 
subjected to one freeze/thaw cycle before analysis [29]. 
This study showed that for most of the common clinical 
analytes, serum samples are stable when stored at 
–80°C, which confirms the validity of using paediatric 
specimens stored under these conditions for the deter­
mination of reference intervals [29]. 
In 2013, CALIPER evaluated the effects of fasting and 
sample collection time on 38 routine clinical chemistry 
analytes using either the Roche Cobas Intergra 400 or 
the Ortho Vitros 5.1 FS Chemistry Systems Analyser [27]. 
This was the first study to evaluate these factors using 
such a broad array of analytes, and, notably, the first 
study to examine these variables in a paediatric popula­
tion. Four blood samples were collected from 27 healthy 
children/adolescents (aged 4–18) at specific time points 
throughout the course of one day, and the samples 
collected included both fasted and fed states [27]. 
This study revealed that for certain analytes there 
were significant differences in concentration related to 
non­fasting state and/or time of day of blood draw [27]. 
It is critical for paediatricians to be aware of these 
types of variation and which analytes are affected, as 
an uninformed decision to order non­fasting, random, 
or serial samples can contribute to misdiagnosis or 
mismanagement of patients [27]. 
In 2014, CALIPER studied the short­term biological 
variation of 38 chemistry, lipid, enzyme, and protein 
analytes in the paediatric population using four sam­
ples from 29 healthy subjects (aged 4­18) at different 
time points throughout the course of one day [28]. 
This was the first study to analyze the components 
of biological variation in a healthy paediatric cohort, 
including within­ and between­person biological 
variation, reference change values, and index of 
individuality. These findings generated a wealth of 
information, not only regarding the physiological 
changes that occur within and between individuals, 
but also regarding which quality specifications are 
appropriate for a given test, and how and when to 
use reference intervals [28].
Also in 2014, another sub­study was performed 
to compare paediatric reference intervals calculated 
from hospital­based patient data (using the Hoffman 
approach) to those calculated using samples collected 
from healthy community children and adolescents as 
part of the CALIPER study [30]. Reference intervals cal­
culated from hospital­based data were generally wider 
than those calculated by CALIPER and none fell com­
pletely within the 90% confidence intervals calculated 
by CALIPER [30]. Although using hospital­based patient 
data has an obvious advantage in that it removes the 
need to recruit healthy individuals, this study showed 
that it is not an appropriate method for establishing 
accurate reference intervals [30]. 
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Future directions
CALIPER has made significant advances in ad­
dressing the limitations in paediatric laboratory data by 
establishing up­to­date paediatric reference intervals 
that are accessible to healthcare centres across Cana­
da, and worldwide. 
To date, CALIPER has established robust age­ and 
sex­specific paediatric reference intervals for over 
80 biochemical analytes commonly used in clinical prac­
tice, and has also performed a number of sub­studies 
to further validate and support the clinical application 
of these reference intervals. In addition, CALIPER 
has begun expanding its database for application in 
paediatric centres across the country and globally, by 
performing transference studies for commonly used 
analytical platforms. These transference studies are 
the first step towards the development of ‘common 
reference intervals’, which can be used to interpret test 
results obtained from different laboratories using diffe­
rent analytical equipment. ‘Common reference intervals’ 
are determined through collaboration between national 
or international laboratories, which use analytical me­
thods that are traceable to a common reference method. 
Although major obstacles exist, including the lack of 
harmonisation of methods by manufacturers as well as 
the paucity of reference materials and methods for the 
majority of analytes, the concept of common reference 
intervals has been suggested as representing at least 
in part ‘the way forward’ [31]. 
The CALIPER initiative serves as a key starting 
point towards achieving this goal, as a key objective of 
CALIPER is to transfer its paediatric reference interval 
database to all major analytical platforms to facilitate 
application of common reference intervals in paediatric 
centres across Canada. 
Other CALIPER initiatives include expanding the 
database to include reference values for the adult and 
geriatric populations. This will aid improved healthcare 
for patients of all ages, and the same rigorous statistical 
approach will be employed to examine samples from 
healthy community subjects. CALIPER has already 
begun collaboration with Statistics Canada to obtain 
access to the vast amount of data and blood sam­
ples that have been collected through the Canadian 
Health Measures Survey (CHMS) from subjects aged 
3–79 years, in order to establish age­ and sex­specific 
reference intervals for the adult and geriatric popula­
tions. CALIPER will also use this data to update our 
paediatric reference intervals, in order to generate 
a comprehensive database that is truly representative 
of the Canadian population. In addition, CALIPER also 
plans to stay up to date by establishing new reference 
intervals for emerging biomarkers of disease that are 
relevant to clinical practice.
The CALIPER project has also been focused on 
knowledge translation initiatives, and has begun to 
disseminate reference intervals through peer­reviewed 
publications, the development of an accessible online 
database (www.caliperdatabase.ca), as well as a new 
smartphone CALIPER reference application (available 
on iTunes) that allows physicians and laboratory 
technicians worldwide to easily access the CALIPER 
database. 
The CALIPER project has made extensive progress 
towards its goal of ensuring that every child presenting 
at any clinic or hospital in Canada or elsewhere benefits 
from the extensive, accurate, and available knowledge 
this project has provided. We will continue to pursue 
this goal through future endeavours. 
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